| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | NEUTRAL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 15.37▲ | 15.27▲ | 15.29▲ | 18.01▼ | 19.61▼ |
| MA10 | 15.33▲ | 15.24▲ | 15.29▲ | 17.65▼ | 24.55▼ |
| MA20 | 15.30▲ | 15.31▲ | 16.58▼ | 19.52▼ | 28.19▼ |
| MA50 | 15.25▲ | 17.14▼ | 17.73▼ | 25.61▼ | 26.10▼ |
| MA100 | 15.32▲ | 17.63▼ | 17.12▼ | 28.63▼ | 23.95▼ |
| MA200 | 16.34▼ | 17.01▼ | 22.38▼ | 27.05▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.012▲ | 0.136▲ | -0.066▼ | 0.151▲ | -1.861▼ |
| RSI | 58.679▲ | 41.601▼ | 37.311▼ | 32.216▼ | 30.553▼ |
| STOCH | 88.540▲ | 48.272 | 26.801 | 65.444 | 27.144 |
| WILL %R | -2.500▲ | -43.382 | -84.087▼ | -90.465▼ | -81.047▼ |
| CCI | 108.790▲ | 77.316 | -32.411 | -107.050▼ | -139.219▼ |
|
Monday, October 26, 2026 03:45 AM
ArriVent BioPharma (NASDAQ:AVBP) delivered early oncology updates with initial Phase 1 results for ARR-217, an investigational antibody-drug conjugate targeting cadherin-17 (CDH17). The candidate, ...
|
|
Monday, October 26, 2026 03:13 AM
ArriVent shared initial Phase 1 results for ARR-217 (MRG007), a cadherin-17 (CDH17)-targeted antibody-drug conjugate. Patient group: Data ...
|
|
Sunday, October 25, 2026 06:00 AM
ArriVent BioPharma, Inc. (Nasdaq: AVBP) reported initial Phase 1 data for ARR-217, a cadherin-17 (CDH17)-targeted antibody-drug conjugate (ADC), in patients with gastrointestinal cancers, according to ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 27/10/26 | 15.41 | 15.69 | 15.01 | 15.395 | 1,436,640 |
| 26/10/26 | 18.14 | 18.16 | 14.78 | 15.36 | 5,827,996 |
| 23/10/26 | 19.00 | 21.23 | 18.18 | 21.00 | 3,278,557 |
| 22/10/26 | 18.93 | 19.68 | 18.78 | 19.20 | 843,700 |
| 21/10/26 | 19.07 | 19.44 | 18.68 | 19.12 | 1,488,615 |
| 20/10/26 | 17.94 | 18.98 | 17.57 | 18.85 | 813,987 |
| 19/10/26 | 16.82 | 18.14 | 16.7309 | 17.94 | 1,012,642 |
| 16/10/26 | 16.86 | 17.23 | 16.485 | 16.66 | 1,332,418 |
| 15/10/26 | 16.40 | 16.91 | 15.97 | 16.79 | 814,743 |
| 14/10/26 | 16.06 | 16.615 | 15.26 | 16.20 | 1,588,012 |
|
|
||||
|
|
||||
|
|